- Ticker 2:TSXV:OGI
- CEO:Greg Engel
Organigram (NYSE:OGI) Stock Price
Organigram (NYSE:OGI) Company Overview
Organigram Holdings is a licensed producer of cannabis and cannabis-derived products. Through its wholly-owned subsidiary, Organigram Inc, the company produces medical marijuana products for patients in Canada.
Aside from its focus on producing for Canadian patients and adult recreational consumers, the company is also currently pursuing the development of international business partnerships.
Organigram has invested in a portfolio of legal adult-use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics, Trailer Park Buds and Trailblazer.
Organigram's primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations.
- Address:35 English Drive, Moncton, NB E1E 3X3, Canada
Organigram (NYSE:OGI) Financials
The latest update from the companyClick Here
Stay updated about
Signup to get updates.
He most recently was CEO with a competitive licensed producer, and graduated from the University of Guelph with an Honours Bachelor of Science in Microbiology.
With this diverse industry and international background, he has extensive experience with both traditional and non-traditional financing and debt offerings. De Luca is also a graduate of York University’s Schulich School of Business.
Prior to joining BML Group, Amirault held varying executive roles including: President of Swiss Chalet North America for the Cara Group of Companies, CEO of Creemore Springs Brewery Ltd, Senior Vice President of Molson Coors Canada, Managing Director of Sleeman Brewing Ltd, along with senior roles at Nestle Canada and The Premium Beer Company of Toronto.